Innovate in the current minimum viable product of INDICASAT for the production and business model of the manufacturing of Viral Transport Medium (MTV in Spanish) necessary for the collection and protection of samples for diagnosis of COVID-19. This will translate in a prompt local response to the Ministry of Health(MINSA) and the health authorities of the region to respond to the global shortage of the reagent. Additionally, the project will explore the most effective knowledge transfer model involving the private sector.

Project Detail

Country

Panama

Project Number

PN-T1263

Approval Date

May 29, 2020

Project Status

Closed

Project Type

Technical Cooperation

Sector

HEALTH

Subsector

DISEASE PREVENTION & CONTROL

Lending Instrument

Multilateral Investment Fund Instrument

Lending Instrument Code

MIF

Modality

-

Facility Type

-

Environmental Classification

Likely to cause minimal or no negative environmental and associated social impacts

Total Cost

USD 270,000.00

Country Counterpart Financing

USD 120,000.00

Original Amount Approved

USD 150,000.00
Financial Information
Operation Number Lending Type Reporting Currency Reporting Date Signed Date Fund Financial Instrument
ATN/ME-18017-PN Non-Sovereign Guaranteed USD - United States Dollar Multilateral Investment Fund II (MIF) - Nonreimbursable
Operation Number ATN/ME-18017-PN
  • Lending Type: Non-Sovereign Guaranteed
  • Reporting Currency: USD - United States Dollar
  • Reporting Date:
  • Signed Date:
  • Fund: Multilateral Investment Fund II (MIF) -
  • Financial Instrument: Nonreimbursable

Can’t find a document? Request information

 Implementation Phase
https://www.iadb.org/document.cfm?id=EZSHARE-252602750-4
Donors Memorandum
PN-T1263 - Plan de operaciones.pdf
Jul. 12, 2021
Spanish

Have an Environmental or Social issue related to IDB projects? File a Complaint